Comparative study of the effect of hypnotherapy and Monstrogol capsule on primary dysmenorrhea in girls living in dormitories of Isfahan University of Medical Science in 2022

Phase 3

Conditions: Primary dysmenorrhea.

Registration Number: IRCT20220203053922N1

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Female

Target Recruitment: 72

Inclusion Criteria

Conscious consent to participate in research
Single students living in dormitories
Suffering age 25-18 years
Having regular menstrual periods
Having primary dysmenorrhea for at least two consecutive previous periods
No application of complementary medicine methods during the last two months
Painful menstruation in most menstrual cycles with a pain score of at least 4 out of 10 according to the Visual Analogue Scale (VAS) during two periodic periods
Hypnosis of people

Exclusion Criteria

Any known disease of the genital tract
Secondary dysmenorrhea
History of abdominal or pelvic surgery
Endometriosis
Tobacco use (cigarettes, hookah and drugs), alcohol
Speech, hearing, and mental problems
Heart, kidney, respiratory, diabetes, asthma, hypothyroidism or hyperthyroidism, epilepsy and other patients in need of medication
Sudden weight loss
Special diet (vegetarian)
Do professional exercise and intense physical exercises
Use of herbs, traditional and complementary medicine during the last two months
Psychological problems and diseases requiring medication (bipolar disorder, psychosis, major depression, obsession, borderline disorders, dependent personality disorder, schizoid personality disorder, paranoid personality disorder) based on self-reported research units
Having coagulation disorders and taking anticoagulants
Existence of depression in the individual based on the score obtained from the DASS21 questionnaire

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: Pain ruler.;Number of pain days. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: Asking the patient.;Bleeding volume. Timepoint: Before. Immediately and two months after the intervention. Method of measurement: PBLAC chart.

Secondary Outcome Measures